Clinical Study Between Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel Formulations

A Randomized, Double-Blind, Multiple-Site, Placebo-Controlled Study Comparing Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel Formulations in the Treatment of Moderate to Severe Acne Vulgaris

A randomized, double-blind, multiple-site, placebo-controlled, parallel-group clinical study conducted to evaluate the bioequivalence of two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel formulations.

Inclusion Criteria:

• healthy men or women, 12 years of age and older
• willing to participate and sign a copy of the informed consent form
• moderate to severe facial acne

Exclusion Criteria:

• history of allergy or hypersensitivity to clindamycin or benzoyl peroxide
• pregnant or lactating women
• evidence of a clinically significant disorder
• receipt of any drugs as part of a research study within 30 days prior to study dosing
• use of systemic, topical or facial products which may interfere with study
• significant facial hair, tattoos, excessive facial scarring, active facial sunburn, or peeling due to sunburn